Aspirin May Stop Growth Of Certain Head Cancers, Harvard Medical School Study

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Researchers have demonstrated, for the first time, that aspirin intake correlates with halted growth of vestibular schwannomas (also known as acoustic neuromas), a sometimes lethal intracranial tumor that typically causes hearing loss and tinnitus. Motivated by experiments in the Molecular Neurotology Laboratory at Mass. Eye and Ear involving human tumor specimens, the researchers from MEE, Harvard Medical School, Massachusetts Institute of Technology and Massachusetts General Hospital performed a retrospective analysis of over 600 people diagnosed with vestibular schwannoma at Mass. Eye and Ear. As reported in a news release on the topic, their research suggests the potential therapeutic role of aspirin in inhibiting tumor growth and motivates a clinical prospective study to assess efficacy of this well-tolerated anti-inflammatory medication in preventing growth of these intracranial tumors.

Hey, check out all the research scientist jobs. Post your resume today!

Back to news